Caleb T. Chu, MD | Authors

University of Utah


Future Directions of Monoclonal Antibody Use in Personalized Lung Cancer Therapy

November 30, 2010

With the new direction in research and clinical trials, treating patients who most benefit from treatment with minimal toxicity will continue to be the mainstay of personalized cancer therapy.